There is now strong evidence demonstrating that bilateral globus pallidus internus (GPi) stimulation improves motor function and disability in patients with severe primary generalised, segmental or cervical dystonia. The improvement is gradual, typically occurring over a period of about six months, with pain and then phasic components dissipating before the tonic elements of dystonia. Controlled data indicate that the benefits of GPi stimulation are in the order of 40-60% and are sustained at three years. Further work is required to better understand variation in the extent of the response. The procedure is usually performed under general anaesthesia and is well tolerated, although minor and hardwarerelated complications are common. GPi stimulation can also provide useful benefit to selected patients with secondary dystonia, with encouraging results reported for tardive dystonia, myoclonic dystonia and pantothenate-kinase-associated neurodegeneration. Currently, it is not known whether the nucleus ventralis intermedius of the thalamus or GPi is the optimal target for the surgical treatment of writer's cramp.
Dystonia is a symptom that involves involuntary muscle contractions that are frequently sustained, but can be phasic. These contractions or spasms frequently result in abnormal posturing or repetitive movements in various parts of the body. Dystonia is often accompanied by tremor.
Dystonia has multiple causes but may be categorised by age at onset or by the underlying aetiology as either primary (idiopathic), which may be sporadic or familial, or secondary, the latter often resulting from a neurodegenerative disorder. 1 The most commonly inherited form of primary dystonia results from a defect in the DYT-1 gene. 2 The specific syndromes of myoclonus-dystonia and dopa-responsive dystonia are classified under the term 'dystonia plus syndromes'. Dystonia can also be categorised anatomically according to the part(s) of the body affected by dystonia:
• focal dystonia -involves a single part of the body, for example spasmodic torticollis (cervical dystonia) or blepharospasm or writer's cramp;
• segmental -involves two or more contiguous regions of the body, for example cervical dystonia or writer's cramp;
• multifocal -involves two or more non-contiguous regions of the body, for example blepharospasm or dystonia in one foot; and
• generalised -involves both legs and at least one other part of the body.
Levodopa may produce considerable amelioration of symptoms in doparesponsive dystonia. Similarly, alcohol, used judiciously, can be very effective in suppressing myoclonus-dystonia. In general, however, dystonia responds poorly to oral medication, although high doses of anticholinergics or benzodiazepines may have beneficial effects in some cases. Botulinum toxin is the treatment of choice for focal dystonia and is widely used for managing patients with blepharospasm, vocal dystonia and spasmodic torticollis, as well as other focal or segmental dystonias. 3, 4 However, in some cases tolerance to treatment, mediated through antibodies to botulinum toxin type A or B, may eventually develop. 3, 4 In the past, cervical denervation procedures were utilised to manage patients with severe medically refractory spasmodic torticollis, but the long-term benefits appear to be modest. 5, 6 Before the advent of deep brain stimulation (DBS), thalamotomy had been deployed with some success. However, bilateral thalamotomies were associated with a significant adverse event profile, in particular speech disturbances. 7 Subsequently, demonstrable efficacy of pallidotomy and globus pallidus internus (GPi) stimulation for dyskinesia, including dystonia, was shown in patients with advanced Parkinson's disease.
GPi stimulation was then introduced for the management of severe, medically refractory dystonia, and is now widely deployed.
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Globus Pallidus Stimulation -Patient Selection
The main determinant of whether a patient with dystonia is suitable for
GPi stimulation is that the patient, following discussions with his or her multidisciplinary DBS team, accepts the risks involved in undergoing 
Globus Pallidus StimulationSurgical Technique
Prior to surgery, patients undergo a 3mm contiguous-slice 
Implantation of the Impulse Generator
The 
Alternative Targets for Deep Brain Stimulation in Dystonia
The use of structures other than the GPi as targets for DBS in patients with dystonic conditions has become infrequent. There are some recent reports on the effectiveness of thalamic (ventralis intermedius
Cervical Dystonia
and ventralis oralis posterior) DBS in writer's cramp. 27 There are some reports that suggest that the subthalamic nucleus is an effective target for DBS in primary and tardive dystonia. 28 It is argued that subthalamic nucleus DBS uses less power and thus prolongs battery life, has immediately beneficial effects (compared with the usual delay of about six months seen after GPi DBS) and is clinically as effective.
However, the overwhelming evidence in the published literature on DBS for dystonia is based on the GPi as the target.
Programming Deep Brain Stimulation in Dystonic Patients
Post-operative programming of the implanted pulse generator following electrode implantation in GPi is more difficult in dystonia than other conditions (for example tremor or Parkinson's disease).
This is because the beneficial effects of GPi stimulation take time to appear. Typically, the benefit of GPi stimulation accrues over a period of about six months, but may take up to a year to optimise. In general, some pain relief occurs first, usually within days, and then the phasic components improve before the tonic components of the dystonia. 29 As surgery is usually performed under general anaesthesia, limited data will be available from theatre to guide post-operative programming. Currently, the most posteroventral portion of GPi is considered to be the optimum site for stimulation in dystonia and contact closest to this area is usually the deepest.
In the Charing Cross Hospital unit, three days after electrode
implantation, each contact is tested with monopolar stimulation set at 135Hz and at a pulse width of 90µs. The voltage is gradually turned up to 4.0V or until adverse effects occur. These may include:
• visual 'phosphenes' (flashes);
• capsular effects (pulling or cramp in the contralateral side of the face or limbs);
• a tight feeling in the mouth;
• dysarthria;
• non-specific giddiness; and
• gait disturbances.
The lowest contact on each electrode with which no adverse effects are experienced on stimulation, or the highest threshold to adverse effects is detected, is then chosen for stimulation. Hospital unit are shown in Table 1 .
Results of Globus Pallidus Stimulation in Primary Generalised Dystonia
Uncontrolled Data
Early reports described improvements of up to 90% in the movement section of the BFMDRS, with the most benefit occurring in children with the DYT-1 deletion. 11, 30 In subsequent case series, benefit in the order of 40-70% was seen and DYT-1 status did not appear to influence the degree of improvement. 10, 17, 23 Benefit may occur within hours of stimulation but is more often delayed, with progressive improvement seen over months (tending to plateau after about six months). 31 The beneficial effects of pallidal DBS in primary generalised dystonia seem to be durable. Several studies include follow-up data at two years, and there are descriptions of small numbers of patients followed post-operatively for over five years.
Prospective, Controlled Data
Recent data from prospective, controlled trials provide more robust evidence for the benefit of pallidal DBS in primary generalised dystonia. [19] [20] [21] [22] The improvements demonstrated were less than those quoted in several of the uncontrolled studies and there was a significant degree of 'response variability', which was largely unexplained. A multicentre French study assessed bilateral pallidal DBS in 22 severely impaired patients with PGD. 21, 22 Controlled videotaped assessments were performed in a randomised, doubleblind manner three months after surgery with the stimulators turned 'off' or 'on'. Uncontrolled assessments followed at six, 12 and 36 months. At three months, there were significant improvements in BFMDRS motor and disablility scale scores compared with baseline, when the stimulators were activated. When 'on' and 'off' stimulator conditions were compared, BFMDRS motor scores were improved during stimulation but no significant change was detected in the total BFMDRS disability score. At one year, patients had improved by 54.6%
in BFMDRS motor and 44% in BFMDRS disability scores compared with baseline. Motor improvement was maintained at three years (mean improvements in the BFMDRS motor and disability scores of 58 and 46%, respectively). Improvement in overall quality of life was noted at one year and maintained at three years. Cognition and mood were not adversely affected. 32 There were five adverse events but no permanent neurological sequelae. 
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Results of Globus Pallidus Stimulation in Primary Cervical Dystonia
GPi stimulation for cervical dystonia was first reported in 1999. 16 Case reports and small case series, sometimes embedded in descriptions of heterogeneous groups of patients, 14, 23, 32 indicated improvements of 50-65% in the severity of cervical dystonia. In a prospective, single-blind study of bilateral pallidal stimulation in 10 patients with severe, medication-resistant cervical dystonia, 15 the TWSTRS severity score had improved by 43% at one year postoperatively. Disability and pain scores were also significantly improved and the total TWSTRS score improved by 59%.
Complications were mild and reversible in four patients.
Results of Globus Pallidus Stimulation in the Secondary Dystonias, Dystonia-plus and Heredodegenerative Syndromes
Uncontrolled reports imply that, in general, secondary dystonias are less responsive to pallidal DBS than primary generalised dystonias (average improvement of approximately 49%). 26 However, it is difficult to generalise in view of the striking diversity of causes in this group; dramatic improvements may be achieved in selected cases, particularly if cranial imaging is normal. Encouraging results have been reported in patients with panthotenate-kinase-associated neurodegeneration, with short-term improvement in severity of over 60%. 26, 33 Tardive dystonia may improve by 50-86% following pallidal DBS. 26, 34, 35 In a few small case series of myoclonus dystonia, treatment with pallidal DBS resulted in average improvements in the order of 50%. 26, 36 Less benefit has been reported in miscellaneous cases of anoxic brain injury, Lesch-Nyhan syndrome, neuroacanthocytosis and GM1-type 3 gangliosidosis.
Adverse Effects
The operative risks are described earlier in this article. Bilateral GPi stimulation in dystonia is preferable to lesion-based surgery in terms of the associated reversibility, adaptability and reduced morbidity.
However, hardware-related complications, including infections and electrode lead displacement (see Figure 1) or fracture, may occur more often in DBS for dystonia, where prominent axial movements cause added mechanical stress. 37 The most common stimulation-related side effects include dysarthria, hypophonia and dysaesthesia; these are usually reversible. 19, 21 There are reports of a 'rebound' effect with the development of status dystonicus upon stopping stimulation. 23 Although most studies indicate that bilateral GPi stimulation in dystonia does not have significant adverse effects on cognition or mood, 32 careful monitoring is warranted.
Conclusion
Bilateral GPi is now an accepted treatment for carefully selected patients with severe forms of primary and secondary dystonia in whom the anticipated benefits are considered to be worth the risks associated with DBS surgery. There are some recent data to suggest that further exploratory work needs to be carried out to assess the relative merits of the subthalamic nucleus target in comparison with
GPi. However, there may still be a role for thalamic DBS in some cases of focal hand dystonia. n 
